Symphony Dynamo

About:

Symphony Dynamo, a biopharmaceutical company, engages in the clinical development of therapeutics to treat cancer and hepatitis B and C.

Top Investors: Symphony Capital

Description:

Symphony Dynamo a biopharmaceutical company, engages in the clinical development of therapeutics to treat hepatitis B, hepatitis C, and cancer. The company was founded in 2006 and is based in Rockville, Maryland. As of December 30, 2009, Symphony Dynamo, Inc. operates as a subsidiary of Dynavax Technologies Corporation.